Adalimumab-Aqvh
2 NDCs across 2 manufacturers|0 Generic,2 Brand
Adalimumab-Aqvh is used to treat juvenile arthritis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, crohn disease and hidradenitis suppurativa, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $650K on Adalimumab-Aqvh across 549 claims for 98 beneficiaries.
Adalimumab-Aqvh is available as 2 NDCs from 2 manufacturers (0 generic, 2 brand), with NADAC prices from $604.15 to $604.15 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
2
competing in market
Price Spread
$604.15 – $604.15
per ML
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Meitheal Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Tumor Necrosis Factor Blocker class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
2 manufacturers producing ADALIMUMAB-AQVH
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
YUSIMRY(CF) 40 MG/0.8 ML PEN | $604.1525 per ML | — |
YUSIMRY(CF) 40 MG/0.8 ML PEN | $604.1525 per ML | — |
Frequently Asked Questions
What is Adalimumab-Aqvh used to treat?
Adalimumab-Aqvh is used to treat juvenile arthritis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, crohn disease and hidradenitis suppurativa, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Adalimumab-Aqvh?
In 2024, Medicare Part D spent $650K on Adalimumab-Aqvh across 549 claims for 98 beneficiaries.
How many Adalimumab-Aqvh products are on the market?
The Adalimumab-Aqvh drug market contains 2 NDCs from 2 manufacturers — 0 generic and 2 brand products.
What is the price range for Adalimumab-Aqvh?
NADAC reference prices for Adalimumab-Aqvh range from $604.1525 to $604.1525 per ML.
Which manufacturers make Adalimumab-Aqvh?
2 manufacturers list Adalimumab-Aqvh in NADAC. Ranked by number of NDCs, the largest are Meitheal Pharmaceuticals Inc. (1), Coherus BioSciences Inc (1).